is presenting today at the 43rd Annual J.P. Morgan Healthcare Conference. During the presentation, Chairman and CEO Michael B. Petras, Jr. will be providing an update on Sotera Health’s business.

CLEVELAND, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ ... Petras, Jr. will present at the 43rd Annual J.P. Morgan Healthcare ...

In a report released today, Brandon Berman from Bank of America Securities maintained a Buy rating on Texas Capital Bancshares (TCBI – Research ...

JPMorgan analyst Stephen Tusa Jr. adjusted the price target for Roper Industries (NASDAQ:ROP) upward to $558 from the ...

In a report released today, Jared Shaw from Barclays maintained a Buy rating on Pinnacle Financial Partners (PNFP – Research Report), with a ...

J.P. Morgan Asset Management found stocks that initiated ... Beverage giant PepsiCo (NASDAQ:PEP) is the first Dividend King to buy for 2025. Its stock has been largely flat for the past few ...

Selective stock-picking and conviction drove HB Biotech’s strong 2024 performance. Read our insights on navigating today’s ...

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

SAN FRANCISCO (Reuters) - The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over what President-elect Donald Trump's priorities ...

ROCHESTER, N.Y.--(BUSINESS WIRE)--Paychex, Inc. (Nasdaq: PAYX ... of Transaction Rationale Transaction Details Advisors J.P. Morgan Securities LLC is serving as the exclusive financial ...

Treasury borrowing has already shot past official forecasts made in the Budget in a blow to Rachel Reeves’s plans to ramp up ...